RA Capital Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,766,830
|
|
||||
2024
Q4 | $82.1M | Sell |
1,766,830
-3,242,823
|
|
||||
2024
Q3 | $144M | Sell |
5,009,653
-2,622,993
|
|
||||
2024
Q2 | $110M | Buy |
7,632,646
+1,314,656
|
|
||||
2024
Q1 | $102M | Hold |
6,317,990
|
|
||||
2023
Q4 | $126M | Hold |
6,317,990
|
|
||||
2023
Q3 | $103M | Hold |
6,317,990
|
|
||||
2023
Q2 | $134M | Hold |
6,317,990
|
|
||||
2023
Q1 | $127M | Hold |
6,317,990
|
|
||||
2022
Q4 | $165M | Buy |
6,317,990
+267,990
|
|
||||
2022
Q3 | $61.8M | Buy |
6,050,000
+950,000
|
|
||||
2022
Q2 | $21.4M | Hold |
5,100,000
|
|
||||
2022
Q1 | $25.4M | Hold |
5,100,000
|
|
||||
2021
Q4 | $34.3M | Hold |
5,100,000
|
|
||||
2021
Q3 | $27.9M | Hold |
5,100,000
|
|
||||
2021
Q2 | $33.4M | Hold |
5,100,000
|
|
||||
2021
Q1 | $42.6M | Hold |
5,100,000
|
|
||||
2020
Q4 | $31.8M | Hold |
5,100,000
|
|
||||
2020
Q3 | $31.8M | Buy |
+5,100,000
|
|